• SENSEX 81,444.66
    -138.64 (--0.17%)
  • BANKNIFTY 55,828.75
    114.60 (+0.21%)
  • Hindustan Zinc
    451.50 378.65(%)
  • Garden Reach Sh.
    3,286.00 3,528.00(%)
  • NTPC
    330.65 292.70(%)
  • Vishal Mega Mart
    121.90 96.05(%)
  • Optiemus Infra.
    706.50 873.65(%)
  • Infosys
    1,615.00 1,307.10(%)
  • IndusInd Bank
    855.20 1,550.00(%)
  • Cochin Shipyard
    2,135.60 1,180.45(%)
  • Reliance Power
    66.85 76.49(%)
  • Electronics Mart
    161.25 261.75(%)
  • Sika Interplant
    1,537.30 1,537.30(%)
  • Sterlite Tech.
    101.50 50.70(%)
  • Tata Motors
    668.00 542.55(%)
  • Sky Gold & Diam.
    344.60 126.59(%)
  • Wockhardt
    1,699.55 552.20(%)
  • S C I
    225.85 384.80(%)
  • Mazagon Dock
    3,237.70 1,917.95(%)
  • Reliance Industr
    1,425.55 1,115.55(%)
  • HDFC Bank
    1,935.70 1,996.30(%)
  • Suzlon Energy
    63.80 46.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Solara Active Pharma Sciences Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 70281.0
  • ISIN : INE624Z01016
524.75 6 (1.09%)
  • As on 18 Jun 2025 (EOD)
  • Today’s Low

    514.35
  • Today’s High

    545.00
  • Open

    526.90
  • Perv Close

    519.10
  • 52W Low

    417.15
  • 52W High

    882.80

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    2,319.71

  • Div & Yield %

    0.00

  • Book Value(₹)

    302.07

  • Debt-Equity Ratio

    1.09

  • AGM Date

    18-Jun-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    0.83

  • Mar.Cap (₹Cr.)

    2,319.71

  • RONW (%)

    0.00

  • ROCE (%)

    0.00

Score Board

  • Equity (₹ in Cr.)

    36.15

  • BV (₹)

    302.10

  • Sales( ₹ in Cr.)

    1,283.76

  • NP (in Cr.)

    -1.08

  • NP Var(%)

    100.0

  • Div%

    0.0

  • CPS (₹)

    27.20

  • EPS (₹)

    -0.30

  • Traded Value (₹ in Lakhs)

    2,305.09

  • 52 Week High

    882.80

  • 52 Week Low

    417.15

  • Price BSE

    520.0

  • Price NSE

    519.00

  • Market Capital( in Cr.)

    2,305.09

  • P/C Ratio

    19.20

  • P/E Ratio

    -1,740.80

  • Price Vs.BV

    -0.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 1,288.92 1,443.81 1,268.34 1,616.88 1,321.75 1,386.68
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,288.92 1,443.81 1,268.34 1,616.88 1,321.75 1,386.68
Other Income 5.37 22.14 18.76 28.41 27.51 12.03
Stock Adjustments -39.27 -7.05 258.75 2.15 54.16 33.79
Total Income 1,255.02 1,458.90 1,545.85 1,647.44 1,403.42 1,432.50
EXPENDITURE :            
Raw Materials 765.75 781.78 912.64 726.56 653.03 738.62
Power and Fuel Cost 122.56 107.95 93.70 85.42 77.68 79.35
Employee Cost 243.92 228.05 234.20 227.63 202.24 183.98
Other Manufacturing Expenses 109.31 90.76 97.87 91.19 89.50 91.58
Selling and Administration Expenses 70.40 67.50 76.39 76.07 74.19 64.70
Miscellaneous Expenses 222.41 26.68 35.43 26.83 22.74 48.38
Employee Benefit Expenses 243.92 228.05 234.20 227.63 202.24 183.98
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,534.35 1,302.72 1,450.23 1,233.70 1,119.38 1,206.61
Operating Profit -279.33 156.18 95.62 413.74 284.04 225.89
Interest 105.97 90.06 75.27 84.47 77.88 82.42
Gross Profit -385.30 66.12 20.35 329.27 206.16 143.47
Depreciation 103.03 110.90 112.01 108.31 93.67 82.79
Profit Before Tax -488.33 -44.78 -91.66 220.96 112.49 60.68
Current Tax 0.00 -0.11 0.00 38.64 20.69 15.96
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 78.54 -22.46 -33.10 -38.64 -20.69 -13.95
Reported Net Profit -566.87 -22.21 -58.56 220.96 112.49 58.67
Extraordinary Items -158.84 -0.45 -4.26 1.65 -0.26 0.32
Adjusted Net Profit -408.03 -21.76 -54.30 219.31 112.75 58.35
Adjustment below Net Profit 0.56 -1.76 2.01 -2.53 -3.85 -10.70
P & L Balance brought forward 250.04 274.01 341.34 142.65 49.67 1.70
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 10.78 19.74 15.66 0.00
P & L Balance carried down -316.27 250.04 274.01 341.34 142.65 49.67
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 30.00 0.00 70.00 20.00 50.00
Dividend Per Share(Rs) 0.00 3.00 0.00 7.00 2.00 5.00
Earnings Per Share-Unit Curr -157.46 -6.17 -16.27 61.50 41.90 22.77
Earnings Per Share(Adj)-Unit Curr -145.12 -5.69 -15.00 56.68 38.62 20.99
Book Value 260.39 417.54 424.18 443.30 370.50 333.12
Book Value(Adj)-Unit Curr 239.98 384.83 390.94 408.56 341.46 307.01

Shareholding Pattern

  • Promoter Group

    37.94%

  • Public Share Holding

    62.06%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 536,835 1.12 536,835 2
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,401,417 7.08 3,401,417 11
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 523,384 1.09 523,384 1
Others 0 0.00 0 0
Sub Total 18,231,281 37.94 18,231,281 20
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 1,354 0.00 1,354 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 1,308 0.00 1,308 4
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 7,029,907 14.63 7,029,907 55
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 616,107 1.28 616,107 3
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 638,845 1.33 638,845 4
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 8,287,521 17.25 8,287,521 67
2] Non Institution
Bodies Corporate 4,030,201 8.39 4,029,762 492
Clearing Members 480 0.00 480 2
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 534,109 1.11 532,796 1,608
Foreign Non Institution Other 1,258,649 2.62 1,258,649 2
Hindu Undivided Families 581,761 1.21 581,668 1,569
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 2,564,573 5.34 2,564,573 45
Individuals holding nominal share capital up to Rs. 1 lakh 8,520,931 17.73 8,498,228 71,923
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 4,031 0.01 4,031 3
Others 18,906 0.04 18,906 3
Sub Total 21,534,220 44.81 21,509,672 75,704
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 48,053,022 100.00 48,028,474 75,791

Company Background

Solara Active Pharma Sciences LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Solara Active Pharma Sciences Ltd
  • BSE Code : 70281.0
  • ISIN : INE624Z01016
  • Incorporation Year

    2017

  • Registered Office

    201 Devavrata Sector 17 Vashi
    Navi Mumbai, Mumbai,
    Maharashtra-400703

  • Telephone

    91-22-27892924

  • FAX

    91-22-27892942

  • Chairman

    RAJAGOPALAN RAMAKRISHNAN

  • Managing Director

    Sandeep Rao

  • Company Secretary

    Pooja Jaya Kumar

  • Auditor

    Deloitte Haskins & Sells LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Cameo Corporate Services Ltd
    Subramanian Building,
    1ST Floor No 1,Club House Road
    Mumbai - Chennai - 600002

Solara Active Pharma Sciences Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Solara Active 526.40 1,294.29 1,288.92 -1,754.67 0.00
Abbott India 31,507.40 6,097.18 5,848.91 47.34 44.71
Astrazeneca Phar 9,734.65 1,330.33 1,295.53 210.25 33.26
P & G Health Ltd 5,956.00 1,166.89 1,151.26 39.36 39.76
Glaxosmi. Pharma 3,284.70 3,866.05 3,723.49 60.55 58.72
Cipla 1,498.35 17,645.00 16,574.34 23.46 20.10
Amrutanjan Healt 716.70 437.58 421.23 40.77 20.84
Fermenta Biotec. 327.65 315.24 307.09 14.26 4.10
Guj. Themis Bio. 325.10 174.19 169.82 72.57 44.82
Bliss GVS Pharma 139.80 638.96 605.46 21.34 11.19
Ambalal Sarabhai 36.28 11.70 3.81 33.59 1.92